allotrap and Colitis
allotrap has been researched along with Colitis in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Boismenu, R; Buelow, R; Chen, Y; Chou, K; El-Sheikh, A | 1 |
| Bourreille, A; Buelow, R; de la Blétière, DR; Doubremelle, M; Galmiche, JP; Segain, JP; Toquet, C | 1 |
Trials
1 trial(s) available for allotrap and Colitis
| Article | Year |
|---|---|
RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
Topics: Adolescent; Adult; Aged; Animals; Anti-Inflammatory Agents; Colitis; Crohn Disease; Female; Histocompatibility Antigens Class I; Humans; Interferon-gamma; Interleukin-1; Intestinal Mucosa; Male; Middle Aged; Models, Animal; Peptides; Prospective Studies; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2003 |
Other Studies
1 other study(ies) available for allotrap and Colitis
| Article | Year |
|---|---|
Orally administered RDP58 reduces the severity of dextran sodium sulphate induced colitis.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Inflammatory Agents; Apoptosis; Cell Division; Colitis; Dextran Sulfate; Epithelial Cells; Female; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Neutrophil Infiltration; Peptides; Tumor Necrosis Factor-alpha | 2002 |